Concepedia

Lori Muffly

LM

Statistics

Publications

80

Citations

4.6K

H-Index

33

Active since

2009

Affiliations

Stanford University(Current)

Stanford Blood Center

Stanford Medicine

University of Chicago

University of California, Davis

Lori Muffly is an author at Stanford University specializing in oncology, hematology, and medicine.

Publications per year

2009–2025

80

Publications

80

CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial

Jay Y. Spiegel, Shabnum Patel, Lori Muffly et al. · Nature Medicine · 2021 · 572 citations · Full text

Medicine, Hematology, Oncology +17

Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States

Lori Muffly, Marcelo C. Pasquini, Michael J. Martens et al. · Blood · 2017 · 296 citations · Full text

Medicine, Geriatric Medicine, Hematology +14

Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients

Lori Muffly, Masha Kocherginsky, Wendy Stock et al. · Haematologica · 2014 · 260 citations · Full text

Medicine, Geriatric Medicine, Hematology +16

Post-infusion CAR TReg cells identify patients resistant to CD19-CAR therapy

Zinaida Good, Jay Y. Spiegel, Bita Sahaf et al. · Nature Medicine · 2022 · 244 citations · Full text

Life Sciences, Immunology, Oncology +12

Cost Effectiveness of Chimeric Antigen Receptor T-Cell Therapy in Multiply Relapsed or Refractory Adult Large B-Cell Lymphoma

John K. Lin, Lori Muffly, Michael A. Spinner et al. · Journal of Clinical Oncology · 2019 · 230 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +17

1–5 of 80